Our vocation

We are committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.

Discover our 4 values:

Dare to innovate:

We undertake to provide innovative therapeutic solutions. Driven by a pioneering spirit, we dare, we strive, and we accomplish together.

Care:

We prepare for the future by embracing human and environmental dimensions. Our concern for the health and fulfillment of all is our driving force.

Grow by sharing:

Every opportunity to work together contributes to the common good. Whoever we are, wherever we are, we grow and develop by working together, building on one another’s experiences and contributions.

Commit to succeed:

The continuous development of the Group is vital. Whatever challenges we face, we are committed to keeping our promises.

22000

employees in
66 countries

100 million

patients treated each day
worldwide
with Servier medicines.

25％

of our turnover,
excluding generics,
is reinvested in R&D.

€4.7 billion euros

in revenue comprising €3.2 billion
for brand-name medicines
€1.4 billion for generic medicines.

4 major R&D areas

oncology,
cardiometabolism, neuroscience
and immuno-inflammation

Our news

Servier signed a definitive agreement to acquire Symphogen

Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline

06/04/2020